title: Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity.
authors.affiliation: Pfizer Worldwide Research and Development, Groton, Connecticut.
authors.forename: Aidan
authors.initials: A
authors.lastname: Power
authors.affiliation: Institute of Medicine, Washington, DC.
authors.forename: Adam C
authors.initials: AC
authors.lastname: Berger
authors.affiliation: Duke University Institute for Genome Sciences and Policy, Durham, North Carolina.
authors.forename: Geoffrey S
authors.initials: GS
authors.lastname: Ginsburg
mesh_terms: D004345:Drug Industry / Q000191:economics* / Q000639:trends; D058492:Drug Repositioning / Q000191:economics / Q000639:trends*; D023281:Genomics / Q000639:trends*; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D012109:Research Support as Topic; D057170:Translational Research, Biomedical / Q000639:trends; D014481:United States; D014486:United States Food and Drug Administration